BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 10485470)

  • 21. Histone deacetylase 3 represses p15(INK4b) and p21(WAF1/cip1) transcription by interacting with Sp1.
    Huang W; Tan D; Wang X; Han S; Tan J; Zhao Y; Lu J; Huang B
    Biochem Biophys Res Commun; 2006 Jan; 339(1):165-71. PubMed ID: 16298343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Butyrate, a histone deacetylase inhibitor, activates the human IGF binding protein-3 promoter in breast cancer cells: molecular mechanism involves an Sp1/Sp3 multiprotein complex.
    Walker GE; Wilson EM; Powell D; Oh Y
    Endocrinology; 2001 Sep; 142(9):3817-27. PubMed ID: 11517158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
    Wu Y; Zhang X; Salmon M; Zehner ZE
    Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of p21(WAF1/Cip1) transcription through Sp1 sites by histone deacetylase inhibitor apicidin: involvement of protein kinase C.
    Han JW; Ahn SH; Kim YK; Bae GU; Yoon JW; Hong S; Lee HY; Lee YW; Lee HW
    J Biol Chem; 2001 Nov; 276(45):42084-90. PubMed ID: 11551946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RB regulates transcription of the p21/WAF1/CIP1 gene.
    Decesse JT; Medjkane S; Datto MB; Crémisi CE
    Oncogene; 2001 Feb; 20(8):962-71. PubMed ID: 11314031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein.
    Lou Z; Maher VM; McCormick JJ
    Gene; 2005 May; 351():51-9. PubMed ID: 15857802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methyl CpG-binding domain protein 3 mediates cancer-selective cytotoxicity by histone deacetylase inhibitors via differential transcriptional reprogramming in lung cancer cells.
    Noh EJ; Jang ER; Jeong G; Lee YM; Min CK; Lee JS
    Cancer Res; 2005 Dec; 65(24):11400-10. PubMed ID: 16357148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation.
    Santini MP; Talora C; Seki T; Bolgan L; Dotto GP
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9575-80. PubMed ID: 11493684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells.
    Zhao S; Venkatasubbarao K; Li S; Freeman JW
    Cancer Res; 2003 May; 63(10):2624-30. PubMed ID: 12750289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the p21(Waf1/Cip1) promoter by the ets oncogene family transcription factor E1AF.
    Funaoka K; Shindoh M; Yoshida K; Hanzawa M; Hida K; Nishikata S; Totsuka Y; Fujinaga K
    Biochem Biophys Res Commun; 1997 Jul; 236(1):79-82. PubMed ID: 9223430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence of a functional role for p21WAF1/CIP1 down-regulation in synergistic antileukemic interactions between the histone deacetylase inhibitor sodium butyrate and flavopiridol.
    Rosato RR; Almenara JA; Yu C; Grant S
    Mol Pharmacol; 2004 Mar; 65(3):571-81. PubMed ID: 14978235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
    Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
    Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trichostatin A and structurally related histone deacetylase inhibitors induce 5-lipoxygenase promoter activity.
    Klan N; Seuter S; Schnur N; Jung M; Steinhilber D
    Biol Chem; 2003 May; 384(5):777-85. PubMed ID: 12817474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibitors activate p21(WAF1) expression via ATM.
    Ju R; Muller MT
    Cancer Res; 2003 Jun; 63(11):2891-7. PubMed ID: 12782595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone H3 acetylation is associated with reduced p21(WAF1/CIP1) expression by gastric carcinoma.
    Mitani Y; Oue N; Hamai Y; Aung PP; Matsumura S; Nakayama H; Kamata N; Yasui W
    J Pathol; 2005 Jan; 205(1):65-73. PubMed ID: 15586362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of regulatory elements in the human adipose most abundant gene transcript-1 ( apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways.
    Barth N; Langmann T; Schölmerich J; Schmitz G; Schäffler A
    Diabetologia; 2002 Oct; 45(10):1425-33. PubMed ID: 12378384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p21 gene regulation during enterocyte differentiation.
    Archer SY; Johnson JJ; Kim HJ; Hodin RA
    J Surg Res; 2001 Jun; 98(1):4-8. PubMed ID: 11368530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells.
    Lee TH; Chuang LY; Hung WC
    Oncogene; 2000 Aug; 19(33):3766-73. PubMed ID: 10949931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1).
    Zhao Y; Lu S; Wu L; Chai G; Wang H; Chen Y; Sun J; Yu Y; Zhou W; Zheng Q; Wu M; Otterson GA; Zhu WG
    Mol Cell Biol; 2006 Apr; 26(7):2782-90. PubMed ID: 16537920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.